Last reviewed · How we verify
Acetylsalicylic Acid 80 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Acetylsalicylic Acid 80 mg (Acetylsalicylic Acid 80 mg) — CHU de Quebec-Universite Laval.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Acetylsalicylic Acid 80 mg TARGET | Acetylsalicylic Acid 80 mg | CHU de Quebec-Universite Laval | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Acetylsalicylic Acid 80 mg CI watch — RSS
- Acetylsalicylic Acid 80 mg CI watch — Atom
- Acetylsalicylic Acid 80 mg CI watch — JSON
- Acetylsalicylic Acid 80 mg alone — RSS
Cite this brief
Drug Landscape (2026). Acetylsalicylic Acid 80 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/acetylsalicylic-acid-80-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab